CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 68 enrolled
Drug / intervention
Coenzyme Q10 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01032993
NCT01032993Phase 3Completed
CompareCT.gov

Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms

Catherine Buettner·interventional·Posted Dec 16, 2009·Updated Jan 23, 2017

In Brief

A Phase 3 clinical trial evaluating Coenzyme Q10 and Placebo for Pain and 4 related conditions. Completed, enrolled 68 participants across 1 site.

Detailed Summary

This study will evaluate whether a dietary supplement, coenzyme Q10 (CoQ10), will improve muscle symptoms, such as muscle aches, pains, cramps, and/or weakness, which are experienced by some individuals who use statin medications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Weakness, Cramps, Myalgia or Myositis Nos, HMG COA Reductase Inhibitor Adverse Reaction
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 16, 2009
Enrollment StartDec 1, 2009
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 16.5 years ago

Interventions

Coenzyme Q10dietary

300 mg of CoQ10 (three 100 mg chewable tablets) 2 times daily for 4 weeks

Placeboother

Placebo (three chewable tablets) 2 times daily for 4 weeks